MyOva myo-plus
Natural health product licensed in Canada
- Other names
- Brighterlife MyOva myo-plus
- Licence holder
- Brighterlife Health Ltd
- NPN or DIN-HM
- 80097448
- Status
- Active licence
- Licence date
- 6 March 2020
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 100 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Myo-inositol Source : Inositol | 1,000 mg | Not calculated |
| Folate Source : Acide folique | 50 mcg | Not calculated |
| Chrome Source : Citrate de chrome(III) | 25 mcg | 100 µg |
Non-medicinal ingredients
Stéarate de magnésium, Dioxyde de silicium, Cellulose microcristalline, Hydroxyméthyl cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Helps to maintain normal blood glucose levels. Provides support for healthy glucose metabolism. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Helps promote/restore pregnancy rates/fertility in women under 36 years old with PCOS who undergo in vitro fertilization (IVF). Aids in the management of PCOS hormonal and metabolic conditions by promoting healthy glucose metabolism and reducing insulin resistance. May help to support normal menstrual cycle in women with polycystic ovarian syndrome . Helps support ovulation in women with PCOS.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
To ensure a timely treatment of a serious cause of infertility, consult a health care practitioner prior to use. If symptoms persist or worsen, consult a health care practitioner. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are pregnant or breastfeeding. Keep out of reach of children. There is enough drug in this package to seriously harm a child.
Source
Official Health Canada record, licence 80097448
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.